Tag Archives: opioid litigation

Financial Daily Dose 11.18.2019 | Top Story: Aramco Seeks Valuation of $1.7T, Well below Original Goal

BY: Michael D. Reif | November 18, 2019

Saudi Aramco’s slow trickle of IPO-related information continued this weekend, including its goal of setting overall company market value at a staggering $1.7 trillion. The figure, though massive, is still well short of the $2 trillion valuation originally floated by MBS – NYTimes and WSJ and Bloomberg As the 737 Max grounding heads into its … Continue reading

Financial Daily Dose 10.22.2019 | Top Story: WeWork Bailout Would Cost Company $39 billion in Valuation

BY: Michael D. Reif | October 22, 2019

SoftBank’s plan to help bail out WeWork would mean not only a takeover by Masa Son’s crew but also “would slash the co-working company’s valuation to about $8 billion”—a staggering drop of nearly $40 billion. The plan would alleviate WeWork’s cash crunch via a $5 billion loan and an offer to buy more than $1 … Continue reading

Financial Daily Dose 10.21.2019 | Top Story: Four Drug Companies Reach Last-minute Deal to Avoid Start of Federal Opioid Trial

BY: Michael D. Reif | October 21, 2019

A last-minute deal between defendants McKesson, Cardinal Health, AmerisourceBergen, and Teva and plaintiffs’ attorneys means that multidistrict opioid epidemic litigation set to kick off in Ohio federal court today will not feature them, though Walgreens could still see the courtroom today – WSJ In today’s “Don’t count your departures from coalitions of states before they … Continue reading

Financial Daily Dose 10.16.2019 | Top Story: Drug Distributors and Maker in Talks for Multi-billion-dollar Opioid Litigation Settlement

BY: Michael D. Reif | October 16, 2019

A group of three major drug distributors—McKesson, AmerisourceBergen, and Cardinal Health—are in the midst of talks with representatives of state and local governments who have brought more than 2000 opioid-related lawsuits against them in hopes of reaching a global settlement for upwards of $18 billion. They’ve been recently joined by Johnson & Johnson, which has … Continue reading

Financial Daily Dose 10.1.2019 | Top Story: Credit Suisse COO Resigns in Wake of Corporate Spying Scandal

BY: Michael D. Reif | October 1, 2019

Top Tidjane Thiam ally Pierre-Olivier Bouee, Credit Suisse’s COO, has resigned in the wake of an internal probe finding that he “ordered the surveillance of the bank’s former wealth-management chief, Iqbal Khan, without discussing it with Mr. Thiam or other senior bank officials.” Khan left Credit Suisse to join rival UBS Group today – WSJ … Continue reading